Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: comparison of 40 mg o.d. vs 40 mg b.i.d. The X-COVID19 Randomized Clinical Trial
暂无分享,去创建一个
L. Bonacchini | M. Merli | L. Antolini | S. Birocchi | M. Cattaneo | N. Morici | M. Trezzi | G. Podda | M. Valsecchi | F. Serino | M. Agostinis | G. Gazzaniga | G. Massaini | G. Carioti | D. Barberis